FDA Import Refusal 799-5838662-6/11/4 — INTAS PHARMACEUTICALS LTD.
The FDA refused shipment 799-5838662-6/11/4 from INTAS PHARMACEUTICALS LTD. (India) on Feb 26, 2025. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 26, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDY49 NAPROXEN (ANTI-INFLAMMATORY)
- Charges
- 118,75